Terms: = Uterine cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Treatment
3 results:
1. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
[TBL] [Abstract] [Full Text] [Related]
2. Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
Pölcher M; Rottmann M; Brugger S; Mahner S; Dannecker C; Kiechle M; Brambs C; Grab D; Anthuber C; von Koch F; Schnelzer A; Engel J
Gynecol Oncol; 2019 Jul; 154(1):65-71. PubMed ID: 31027900
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
Qu A; Jiang P; Sun H; Jiang W; Jiang Y; Tian S; Wang J
J Gynecol Oncol; 2019 Jan; 30(1):e9. PubMed ID: 30479093
[TBL] [Abstract] [Full Text] [Related]
